Iran Oncology NGS Market (2025-2031) | Companies, Growth, Trends, Share, Industry, Outlook, Size & Revenue, Competitive Landscape, Analysis, Forecast, Segmentation, Value

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 Iran Country Macro Economic Indicators

3.2 Iran Oncology NGS Market Revenues & Volume, 2021 & 2031F

3.3 Iran Oncology NGS Market - Industry Life Cycle

3.4 Iran Oncology NGS Market - Porter's Five Forces

3.5 Iran Oncology NGS Market Revenues & Volume Share, By Technology, 2021 & 2031F

3.6 Iran Oncology NGS Market Revenues & Volume Share, By Application, 2021 & 2031F

3.7 Iran Oncology NGS Market Revenues & Volume Share, By Service, 2021 & 2031F

3.8 Iran Oncology NGS Market Revenues & Volume Share, By Workflow, 2021 & 2031F

3.9 Iran Oncology NGS Market Revenues & Volume Share, By End-use, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Growing prevalence of cancer in Iran

4.2.2 Increasing adoption of Next-Generation Sequencing (NGS) technologies in oncology

4.2.3 Government initiatives and investments in healthcare infrastructure

4.3 Market Restraints

4.3.1 Limited reimbursement policies for NGS testing in oncology

4.3.2 High costs associated with NGS technologies and tests

4.3.3 Lack of skilled professionals in the field of oncology NGS

6.1 Iran Oncology NGS Market, By Technology

6.1.1 Overview and Analysis

6.1.2 Iran Oncology NGS Market Revenues & Volume, By Technology, 2021- 2031F

6.1.3 Iran Oncology NGS Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F

6.1.4 Iran Oncology NGS Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F

6.2 Iran Oncology NGS Market, By Application

6.2.1 Overview and Analysis

6.2.2 Iran Oncology NGS Market Revenues & Volume, By Diagnostics and Screening, 2021- 2031F

6.2.3 Iran Oncology NGS Market Revenues & Volume, By Research Studies, 2021- 2031F

6.3 Iran Oncology NGS Market, By Service

6.3.1 Overview and Analysis

6.3.2 Iran Oncology NGS Market Revenues & Volume, By Platforms and Related Products, 2021- 2031F

6.3.3 Iran Oncology NGS Market Revenues & Volume, By Services, 2021- 2031F

6.4 Iran Oncology NGS Market, By Workflow

6.4.1 Overview and Analysis

6.4.2 Iran Oncology NGS Market Revenues & Volume, By Pre-Sequencing, 2021- 2031F

6.4.3 Iran Oncology NGS Market Revenues & Volume, By Sequencing, 2021- 2031F

6.4.4 Iran Oncology NGS Market Revenues & Volume, By NGS Data Analysis, 2021- 2031F

6.5 Iran Oncology NGS Market, By End-use

6.5.1 Overview and Analysis

6.5.2 Iran Oncology NGS Market Revenues & Volume, By Academic Research, 2021- 2031F

6.5.3 Iran Oncology NGS Market Revenues & Volume, By Clinical Research, 2021- 2031F

6.5.4 Iran Oncology NGS Market Revenues & Volume, By Hospitals & Clinics, 2021- 2031F

6.5.5 Iran Oncology NGS Market Revenues & Volume, By Pharma & Biotech Entities, 2021- 2031F

6.5.6 Iran Oncology NGS Market Revenues & Volume, By Other users, 2021- 2031F

7.1 Iran Oncology NGS Market Export to Major Countries

7.2 Iran Oncology NGS Market Imports from Major Countries

8.1 Percentage increase in the number of oncology NGS tests conducted annually

8.2 Adoption rate of NGS technologies in oncology compared to conventional methods

8.3 Rate of research and development investments in oncology NGS technologies

9.1 Iran Oncology NGS Market Opportunity Assessment, By Technology, 2021 & 2031F

9.2 Iran Oncology NGS Market Opportunity Assessment, By Application, 2021 & 2031F

9.3 Iran Oncology NGS Market Opportunity Assessment, By Service, 2021 & 2031F

9.4 Iran Oncology NGS Market Opportunity Assessment, By Workflow, 2021 & 2031F

9.5 Iran Oncology NGS Market Opportunity Assessment, By End-use, 2021 & 2031F

10.1 Iran Oncology NGS Market Revenue Share, By Companies, 2024

10.2 Iran Oncology NGS Market Competitive Benchmarking, By Operating and Technical Parameters